William Brumskine

机构：Vanderbilt University, Aurum Institute, Vanderbilt University Medical Center · ORCID：0000-0002-1092-9919

发表论文 46 篇 · 总被引 1456 次 · h-index 13

代表论文

• Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women (2024 · New England Journal of Medicine · 被引 473)
• Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial (2024 · The Lancet Infectious Diseases · 被引 41)
• High STI burden among a cohort of adolescents aged 12–19 years in a youth-friendly clinic in South Africa (2024 · PLoS ONE · 被引 7)
• Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study (2025 · EClinicalMedicine · 被引 5)
• Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data (2025 · Journal of the International AIDS Society · 被引 3)
• Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study (2024 · PLOS Global Public Health · 被引 3)